ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

NYSE:ZVIA • US98955K1043

1.55 USD
+0.05 (+3.33%)
At close: Feb 25, 2026
1.42 USD
-0.13 (-8.39%)
After Hours: 2/25/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, ZVIA scores 4 out of 10 in our fundamental rating. ZVIA was compared to 33 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. ZVIA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ZVIA has reported negative net income.
  • ZVIA had a negative operating cash flow in the past year.
  • In the past 5 years ZVIA always reported negative net income.
  • ZVIA had a negative operating cash flow in each of the past 5 years.
ZVIA Yearly Net Income VS EBIT VS OCF VS FCFZVIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • ZVIA has a worse Return On Assets (-23.95%) than 87.88% of its industry peers.
  • ZVIA has a Return On Equity of -28.04%. This is amonst the worse of the industry: ZVIA underperforms 84.85% of its industry peers.
Industry RankSector Rank
ROA -23.95%
ROE -28.04%
ROIC N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ZVIA Yearly ROA, ROE, ROICZVIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • The Gross Margin of ZVIA (48.36%) is comparable to the rest of the industry.
  • ZVIA's Gross Margin has been stable in the last couple of years.
  • ZVIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
ZVIA Yearly Profit, Operating, Gross MarginsZVIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ZVIA has more shares outstanding
  • Compared to 5 years ago, ZVIA has more shares outstanding
  • There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZVIA Yearly Shares OutstandingZVIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZVIA Yearly Total Debt VS Total AssetsZVIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • ZVIA has an Altman-Z score of 7.27. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 7.27, ZVIA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
  • ZVIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.27
ROIC/WACCN/A
WACC8.68%
ZVIA Yearly LT Debt VS Equity VS FCFZVIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.27 indicates that ZVIA has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.27, ZVIA is doing good in the industry, outperforming 75.76% of the companies in the same industry.
  • ZVIA has a Quick Ratio of 1.68. This is a normal value and indicates that ZVIA is financially healthy and should not expect problems in meeting its short term obligations.
  • ZVIA has a better Quick ratio (1.68) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.68
ZVIA Yearly Current Assets VS Current LiabilitesZVIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ZVIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.35%, which is quite impressive.
  • ZVIA shows a small growth in Revenue. In the last year, the Revenue has grown by 6.17%.
  • ZVIA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.62% yearly.
EPS 1Y (TTM)51.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)6.17%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%12.31%

3.2 Future

  • Based on estimates for the next years, ZVIA will show a very strong growth in Earnings Per Share. The EPS will grow by 25.30% on average per year.
  • The Revenue is expected to grow by 6.54% on average over the next years.
EPS Next Y57.23%
EPS Next 2Y33.85%
EPS Next 3Y25.3%
EPS Next 5YN/A
Revenue Next Year5.47%
Revenue Next 2Y6.01%
Revenue Next 3Y6.54%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ZVIA Yearly Revenue VS EstimatesZVIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ZVIA Yearly EPS VS EstimatesZVIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • ZVIA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZVIA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZVIA Price Earnings VS Forward Price EarningsZVIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZVIA Per share dataZVIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ZVIA's earnings are expected to grow with 25.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.85%
EPS Next 3Y25.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ZVIA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEVIA PBC-A

NYSE:ZVIA (2/25/2026, 8:04:00 PM)

After market: 1.42 -0.13 (-8.39%)

1.55

+0.05 (+3.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-05
Earnings (Next)02-25
Inst Owners59.79%
Inst Owner Change14.54%
Ins Owners4.45%
Ins Owner Change-7.89%
Market Cap116.25M
Revenue(TTM)162.85M
Net Income(TTM)-14.37M
Analysts80
Price Target4.66 (200.65%)
Short Float %4.47%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.9%
Min EPS beat(2)38.08%
Max EPS beat(2)77.72%
EPS beat(4)3
Avg EPS beat(4)39.45%
Min EPS beat(4)-12.04%
Max EPS beat(4)77.72%
EPS beat(8)7
Avg EPS beat(8)29.47%
EPS beat(12)11
Avg EPS beat(12)32.89%
EPS beat(16)14
Avg EPS beat(16)28.21%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)1.81%
Max Revenue beat(2)4.61%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-1.79%
Max Revenue beat(4)4.61%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.72%
Revenue beat(16)8
Avg Revenue beat(16)-0.15%
PT rev (1m)-2.42%
PT rev (3m)-1.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 2.27
P/tB 2.42
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS2.17
BVpS0.68
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -23.95%
ROE -28.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.36%
FCFM N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
F-Score5
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.71%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.68
Altman-Z 7.27
F-Score5
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)104.57%
Cap/Depr(5y)142.96%
Cap/Sales(3y)0.92%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y57.23%
EPS Next 2Y33.85%
EPS Next 3Y25.3%
EPS Next 5YN/A
Revenue 1Y (TTM)6.17%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%12.31%
Revenue Next Year5.47%
Revenue Next 2Y6.01%
Revenue Next 3Y6.54%
Revenue Next 5YN/A
EBIT growth 1Y47.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year75.62%
EBIT Next 3Y31.29%
EBIT Next 5YN/A
FCF growth 1Y50.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.27%
OCF growth 3YN/A
OCF growth 5YN/A

ZEVIA PBC-A / ZVIA FAQ

What is the ChartMill fundamental rating of ZEVIA PBC-A (ZVIA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ZVIA.


What is the valuation status for ZVIA stock?

ChartMill assigns a valuation rating of 1 / 10 to ZEVIA PBC-A (ZVIA). This can be considered as Overvalued.


What is the profitability of ZVIA stock?

ZEVIA PBC-A (ZVIA) has a profitability rating of 1 / 10.


Can you provide the financial health for ZVIA stock?

The financial health rating of ZEVIA PBC-A (ZVIA) is 8 / 10.